Stifel reiterates Fox Factory stock rating on margin boost

Stifel reiterated its Buy rating and $25 price target on Fox Factory after the $225 million Marucci divestiture removed a business with a $12.7 million first-half fiscal 2026 GAAP operating loss and a negative 16.0% operating margin. The sale is expected to add 240bps to EBIT margin, reduce net leverage from 3.7x to 2.7x initially and about 2.5x after collection of a $25 million seller note. Fox Factory also beat Q2 expectations, reporting adjusted EPS of $0.37 versus $0.185 consensus and $358.1 million in revenue versus $354.47 million expected.

Analysis

The strategic value is not the sale proceeds alone but the removal of a structurally dilutive business from the consolidated earnings base. FOXF now has a cleaner path for gross-margin recovery through manufacturing utilization, procurement savings, and reduced management distraction; this can support a disproportionate equity rerating if revenue merely stabilizes. The key debate shifts from turnaround credibility to whether its core powered-vehicle and cycling end markets can sustain even low-single-digit organic growth without renewed promotional pressure.

Near term, the stock may remain constrained by the loss of divested revenue and by investors discounting the durability of cost actions. Over the next 1-3 months, the relevant catalyst is a guide-up or, more likely, confirmation that core EBITDA dollars are holding despite the smaller revenue base; a modest upward revision to normalized margin expectations would matter more than a sales beat. Over 6-18 months, lower interest expense and improved free-cash-flow conversion create optionality for deleveraging, bolt-on acquisitions, or share repurchases, each of which could narrow the valuation discount to higher-quality specialty component peers.

The contrarian risk is that margin accretion is being annualized too aggressively: cost reductions can mask weak OEM order patterns for several quarters, while aftermarket demand is sensitive to discretionary spending and dealer inventory. The thesis is falsified if core sales decline materially for two consecutive quarters, adjusted EBITDA margin fails to expand from current normalized levels, or net leverage stops declining despite the reduced debt burden. Given limited evidence on segment-level order books and channel inventory, this is a monitored turnaround rather than a high-conviction momentum trade.

Key Decisions for Investors

• Initiate a starter long FOXF over the next 2-4 weeks, sized at 50-75 bps of NAV, only if management reaffirms or raises full-year core-margin expectations at the next update. Target a 25-35% upside over 6-12 months from earnings normalization and multiple rerating; cut the position if core revenue misses guidance by more than 5% or leverage rises quarter-over-quarter.
• Add to FOXF following evidence of two sequential quarters of core EBIT-margin improvement and positive free-cash-flow conversion. This is the cleaner confirmation signal than a headline revenue beat, because the investment case depends on operating leverage rather than top-line scale.
• For beta-controlled exposure, pair long FOXF against a partial short in XLY rather than against a direct operating peer. The objective is to isolate company-specific margin and balance-sheet improvement while reducing discretionary-demand and rate sensitivity; reassess if the relative spread widens 15% without a fundamental revision.
• Do not buy FOXF calls until implied volatility, available maturities, and open interest are verified. If liquid 6-9 month calls are available at reasonable implied volatility, use a call spread rather than outright calls to express the rerating thesis while limiting exposure to a slow recovery in end-market demand.